Royalty Pharma (RPRX) announced that its board of directors has declared a dividend for the first quarter of 2026 of $0.235 per Class A ordinary share, reflecting a 6.8% increase in the company’s quarterly dividend over the previous quarter’s dividend. The dividend will be paid on March 10, 2026 to shareholders of record at the close of business on February 20, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RPRX:
- Royalty Pharma acquires reaming royalty interest in Evrysdi for $240M upfront
- Royalty Pharma Announces Planned Legal Leadership Transition
- Royalty Pharma Gains From FDA Approval of MYQORZO
- Royalty Pharma acquires royalty interest in Nuvalent’s neladalkib, zidesamtinib
- Royalty Pharma price target raised to $45 from $42 at TD Cowen